Mohlo by se vám také líbit

Více informací o knize Renal Anemia

• Parametry knihy
• Anotace
• Oblíbené z jiného soudku

Nákupem získáte 168 bodů

Anotace knihy

Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management.

Parametry knihy

Zařazení knihy Knihy v angličtině Medicine Clinical & internal medicine Haematology

• Plný název: Renal Anemia
• Podnázev: Conflicts and Controversies
• Autor: Onyekachi Ifudu
• Jazyk: Angličtina
• Vazba: Pevná
• Počet stran: 145
• EAN: 9781402006784
• ISBN: 1402006780
• ID: 01414834
• Nakladatelství: Springer-Verlag New York Inc.
• Hmotnost: 900 g
• Rozměry: 235 × 155 × 13 mm
• Datum vydání: 02. July 2002

Oblíbené z jiného soudku

---

---

---